Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

MMP12, lung function, and COPD in high-risk populations.

Hunninghake GM, Cho MH, Tesfaigzi Y, Soto-Quiros ME, Avila L, Lasky-Su J, Stidley C, Melén E, Söderhäll C, Hallberg J, Kull I, Kere J, Svartengren M, Pershagen G, Wickman M, Lange C, Demeo DL, Hersh CP, Klanderman BJ, Raby BA, Sparrow D, Shapiro SD, Silverman EK, Litonjua AA, Weiss ST, Celedón JC.

N Engl J Med. 2009 Dec 31;361(27):2599-608. doi: 10.1056/NEJMoa0904006. Epub 2009 Dec 16.

2.

Chronic obstructive pulmonary disease in non-smokers.

Salvi SS, Barnes PJ.

Lancet. 2009 Aug 29;374(9691):733-43. doi: 10.1016/S0140-6736(09)61303-9. Review.

PMID:
19716966
3.

Community woodstove changeout and impact on ambient concentrations of polycyclic aromatic hydrocarbons and phenolics.

Ward TJ, Palmer CP, Houck JE, Navidi WC, Geinitz S, Noonan CW.

Environ Sci Technol. 2009 Jul 15;43(14):5345-50.

4.

Urinary levoglucosan as a biomarker of wood smoke exposure: observations in a mouse model and in children.

Migliaccio CT, Bergauff MA, Palmer CP, Jessop F, Noonan CW, Ward TJ.

Environ Health Perspect. 2009 Jan;117(1):74-9. doi: 10.1289/ehp.11378. Epub 2008 Aug 15.

5.

Difference in airflow obstruction between Hispanic and non-Hispanic White female smokers.

Sood A, Stidley CA, Picchi MA, Celedón JC, Gilliland F, Crowell RE, Belinsky SA, Tesfaigzi Y.

COPD. 2008 Oct;5(5):274-81. doi: 10.1080/15412550802363345.

6.

GATA4 is a direct transcriptional activator of cyclin D2 and Cdk4 and is required for cardiomyocyte proliferation in anterior heart field-derived myocardium.

Rojas A, Kong SW, Agarwal P, Gilliss B, Pu WT, Black BL.

Mol Cell Biol. 2008 Sep;28(17):5420-31. doi: 10.1128/MCB.00717-08. Epub 2008 Jun 30.

7.

Risk of lung cancer from residential heating and cooking fuels in Montreal, Canada.

Ramanakumar AV, Parent ME, Siemiatycki J.

Am J Epidemiol. 2007 Mar 15;165(6):634-42. Epub 2006 Dec 22.

8.

Woodsmoke health effects: a review.

Naeher LP, Brauer M, Lipsett M, Zelikoff JT, Simpson CD, Koenig JQ, Smith KR.

Inhal Toxicol. 2007 Jan;19(1):67-106. Review.

PMID:
17127644
9.

Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence.

Takahashi A, Ohtani N, Yamakoshi K, Iida S, Tahara H, Nakayama K, Nakayama KI, Ide T, Saya H, Hara E.

Nat Cell Biol. 2006 Nov;8(11):1291-7. Epub 2006 Oct 8.

PMID:
17028578
10.

Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data.

Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ.

Lancet. 2006 May 27;367(9524):1747-57.

PMID:
16731270
11.

Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort.

Belinsky SA, Liechty KC, Gentry FD, Wolf HJ, Rogers J, Vu K, Haney J, Kennedy TC, Hirsch FR, Miller Y, Franklin WA, Herman JG, Baylin SB, Bunn PA, Byers T.

Cancer Res. 2006 Mar 15;66(6):3338-44.

12.

Wood smoke exposure and risk of chronic obstructive pulmonary disease.

Orozco-Levi M, Garcia-Aymerich J, Villar J, Ramírez-Sarmiento A, Antó JM, Gea J.

Eur Respir J. 2006 Mar;27(3):542-6.

13.

Interpretative strategies for lung function tests.

Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J.

Eur Respir J. 2005 Nov;26(5):948-68. No abstract available.

14.

Management of patients with COPD.

McCaughan F, Spiro SG.

Lancet. 2004 Dec 4-10;364(9450):2015. No abstract available.

PMID:
15582051
15.

Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.

Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, Grimes MJ, Harms HJ, Tellez CS, Smith TM, Moots PP, Lechner JF, Stidley CA, Crowell RE.

Cancer Res. 2002 Apr 15;62(8):2370-7.

16.

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLD Scientific Committee.

Am J Respir Crit Care Med. 2001 Apr;163(5):1256-76. Review. No abstract available.

PMID:
11316667
17.

Gender-related differences in severe, early-onset chronic obstructive pulmonary disease.

Silverman EK, Weiss ST, Drazen JM, Chapman HA, Carey V, Campbell EJ, Denish P, Silverman RA, Celedon JC, Reilly JJ, Ginns LC, Speizer FE.

Am J Respir Crit Care Med. 2000 Dec;162(6):2152-8.

PMID:
11112130
18.

Predicting lung cancer by detecting aberrant promoter methylation in sputum.

Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG, Belinsky SA.

Cancer Res. 2000 Nov 1;60(21):5954-8.

19.

Spirometric reference values from a sample of the general U.S. population.

Hankinson JL, Odencrantz JR, Fedan KB.

Am J Respir Crit Care Med. 1999 Jan;159(1):179-87.

PMID:
9872837
20.

Pulmonary function changes in children associated with fine particulate matter.

Koenig JQ, Larson TV, Hanley QS, Rebolledo V, Dumler K, Checkoway H, Wang SZ, Lin D, Pierson WE.

Environ Res. 1993 Oct;63(1):26-38.

PMID:
8404772
Items per page

Supplemental Content

Write to the Help Desk